Abstract:Reductions in hydrogen sulfide (H2S) production have been implicated in the pathogenesis of hypertension; however, no studies have examined the functional role of hydrogen sulfide in hypertensive heart disease. We hypothesized that the endogenous production of hydrogen sulfide would be reduced and exogenous hydrogen sulfide would ameliorate cardiac dysfunction in Nω-nitro- L-arginine methyl ester ( L-NAME)-induced hypertensive rats. Therefore, this study investigated the cardioprotective effects of hydrogen sulfide on L-NAME-induced hypertensive heart disease and explored potential mechanisms. The rats were randomly divided into five groups: Control, Control + sodium hydrosulfide (NaHS), L-NAME, L-NAME + NaHS, and L-NAME + NaHS + glibenclamide (Gli) groups. Systolic blood pressure was monitored each week. In Langendorff-isolated rat heart, cardiac function represented by ±LV dP/dtmax and left ventricular developing pressure was recorded after five weeks of treatment. Hematoxylin and Eosin and Masson's trichrome staining and myocardium ultrastructure under transmission electron microscopy were used to evaluate cardiac remodeling. The plasma nitric oxide and hydrogen sulfide concentrations, as well as nitric oxide synthases and cystathionine-γ-lyase activity in left ventricle tissue were determined. The protein expression of p-Akt, Akt, p-eNOS, and eNOS in left ventricle tissue was analyzed using Western blot. After five weeks of L-NAME treatment, there was a time-dependent hypertension, cardiac remodeling, and dysfunction accompanied by a decrease in eNOS phosphorylation, nitric oxide synthase activity, and nitric oxide concentration. Meanwhile, cystathionine-γ-lyase activity and hydrogen sulfide concentration were also decreased. NaHS treatment significantly increased plasma hydrogen sulfide concentration and subsequently promoted the Akt/eNOS/NO pathway which inhibited the development of hypertension and attenuated cardiac remodeling and dysfunction. The cardioprotective effects of NaHS were counteracted by Gli which inhibited the Akt/eNOS/NO pathway. This suggests that the effects of hydrogen sulfide were mediated by the activation of the KATP channels. In conclusion, hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease via the activation of the Akt/eNOS/NO pathway, which was mediated by KATP channels. Impact statement 1. We found that H2S ameliorated L-NAME-induced cardiac remodeling and dysfunction, and played a protective role in L-NAME-induced hypertensive heart disease, which the existing studies have not reported. 2. H2S activated the Akt/eNOS/NO pathway, thereby playing a cardioprotective role in L-NAME-induced hypertensive heart disease. 3. The cardioprotective effect of H2S was mediated by ATP-sensitive potassium channels.

The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension

Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis

Hydrogen Sulfide Improves Endothelial Dysfunction in Hypertension by Activating Peroxisome Proliferator-Activated Receptor Delta/endothelial Nitric Oxide Synthase Signaling.

Hydrogen Sulfide Improves Endothelial Dysfunction Via Downregulating BMP4/COX-2 Pathway in Rats with Hypertension.

Hydrogen Sulfide Improves Myocardial Remodeling Via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.

Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats

[Hypotensive Effects of Hydrogen Sulfide Via Attenuating Vascular Inflammation in Spontaneously Hypertensive Rats].

Hydrogen Sulfide Ameliorated L-NAME-induced Hypertensive Heart Disease by the Akt/eNOS/NO Pathway

Hydrogen sulfide ameliorates hypertension and vascular dysfunction induced by insulin resistance in rats by reducing oxidative stress and activating eNOS

The role of hydrogen sulfide system in the pathogenesis of renovascular hypertension in rats

H2S Prevents Cyclosporine A-Induced Vasomotor Alteration in Rats

Hydrogen Sulfide in Paraventricular Nucleus Attenuates Blood Pressure by Regulating Oxidative Stress and Inflammatory Cytokines in High Salt-Induced Hypertension

Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats.

The antihypertension effect of hydrogen sulfide (H2S) is induced by activating VEGFR2 signaling pathway

Using mechanism-based combinations of H2S-donors to maximize the cardioprotective action of H2S

Prophylactic Treatment with Hydrogen Sulphide Can Prevent Renal Ischemia-Reperfusion Injury in L-NAME Induced Hypertensive Rats with Cisplatin-Induced Acute Renal Failure

Inhibition of NADPH Oxidase 4-Related Signaling by Sodium Hydrosulfide Attenuates Myocardial Fibrotic Response.

H2S Protects Against Pressure Overload–Induced Heart Failure Via Upregulation of Endothelial Nitric Oxide Synthase

Central cardiovascular effect of hydrogen sulfide and its possible mechanism

Effect of Hydrogen Sulfide on Oxidative Stress in Hypoxic Pulmonary Hypertension

[Changes of Endogenous Hydrogen Sulfide (H2S) in Hypertensive Rats].